This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US FTC to consider AI report, drug rebate policy statement in June 16 open meeting

( June 9, 2022, 18:27 GMT | Official Statement) -- MLex Summary: US Federal Trade Commission Chair Lina Khan has called a public meeting for June 16 to discuss two key policy initiatives. In the first, the FTC will consider a policy statement describing the FTC’s intent to examine rebates and fees paid by drug manufacturers to pharmacy benefit managers and others in exchange for disfavoring the lowest-cost drug products, including in the case of insulin. The commission will also consider whether to issue a report to Congress highlighting current uses of artificial intelligence to combat specific online harms.Text of FTC statement follows in full:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections